Cleared Traditional

Ultimate rTMS for OCD (M-series)

K243459 · Brain Ultimate, Inc. · Neurology
Apr 2025
Decision
160d
Days
Class 2
Risk

About This 510(k) Submission

K243459 is an FDA 510(k) clearance for the Ultimate rTMS for OCD (M-series), a Transcranial Magnetic Stimulation System For Obsessive-compulsive Disorder (Class II — Special Controls, product code QCI), submitted by Brain Ultimate, Inc. (Alpharetta, US). The FDA issued a Cleared decision on April 17, 2025, 160 days after receiving the submission on November 8, 2024. This device falls under the Neurology review panel. Regulated under 21 CFR 882.5802.

Submission Details

510(k) Number K243459 FDA.gov
FDA Decision Cleared SESE
Date Received November 08, 2024
Decision Date April 17, 2025
Days to Decision 160 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code QCI — Transcranial Magnetic Stimulation System For Obsessive-compulsive Disorder
Device Class Class II — Special Controls
CFR Regulation 21 CFR 882.5802
Definition External Device That Uses Magnetic Fields To Induce Neural Activity In The Cerebral Cortex To Treat Neurological And Psychiatric Disorders And Conditions. It Is Not Intended For Applying Or Focusing Magnetic Fields Towards Brain Areas Outside Cerebral Cortex (e.g., Cerebellum).

Similar Devices — QCI Transcranial Magnetic Stimulation System For Obsessive-compulsive Disorder

All 8
BTL-99-OC
K230657 · BTL Industries, Inc. · Feb 2024
CloudTMS Edge for OCD
K233742 · Teleemg, LLC · Dec 2023
OCD MT Cap (85-00397-000)
K231350 · Neuronetics · Jun 2023
CloudTMS for OCD
K221129 · Teleemg, LLC · Mar 2023
NeuroStar Advanced Therapy for adjunctive treatment of OCD, NeuroStar Advanced Therapy System, NeuroStar TMS Therapy System, NeuroStar Advanced Therapy for Mental Health, NeuroStar
K212289 · Neuronetics, Inc. · May 2022
MagVenture TMS Therapy ? for treatment of OCD, MagVenture TMS Therapy system
K193006 · Tonica Elektronik A/S · Aug 2020